Coronary artery constriction by the isoprostane 8-epi prostaglandin F-2 alpha

被引:135
作者
Kromer, BM [1 ]
Tippins, JR [1 ]
机构
[1] UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,DEPT BIOCHEM,LONDON SW7 2AY,ENGLAND
关键词
isoprostane; ischaemia; oxidant stress; coronary artery disease;
D O I
10.1111/j.1476-5381.1996.tb16033.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 This study was undertaken to compare the effects of 8-epi prostaglandin F-2 alpha (8-epi PGF(2 alpha)) to those of prostaglandin F-2 alpha (PGF(2 alpha)) and U46619, a thromboxane mimetic, on ovine, bovine and porcine coronary arteries. 2 8-epi PGF(2 alpha) constricted porcine and bovine coronary arteries in a concentration-dependent manner with EC(50) values of 689.0 +/- 229.3 and 1361.0 +/- 272.3 nM, respectively, but had no effect on ovine coronary arteries. 3 U46619 was a potent vasoconstrictor of porcine, ovine and bovine coronary arteries with EC(50) values of 33.0 +/- 23.5, 373.3 +/- 69.7 and 254.1 +/- 134.3 nM, respectively. E(max) values were significantly greater than those obtained with 8-epi PGF(2 alpha). 4 PGF(2 alpha) constricted porcine and bovine coronary arteries in a concentration-dependent manner with EC(50) values of 1631.0 +/- 207.6 and 3644.0 +/- 344.8 nM, respectively, but had no effect on ovine coronary arteries. 5 Concentration-dependent constriction to U46619 in porcine coronary arteries was competitively inhibited by SQ29548 (10(-8) M to 10(-7) M) and BM13505 (10(-8) M to 10(-6) M) with no decrease in maximal responses. 6 Concentration-dependent constriction to 8-epi PGF(2 alpha) in porcine coronary arteries was inhibited in a concentration-dependent manner by SQ29548 (10(-8) M to 10(-7) M) and BM13505 (10(-8) M to 10(-6) M). However, the inhibition was associated with a decrease in maximal response. 6 Concentration-dependent constriction to 8-epi PGF(2 alpha) in porcine coronary arteries was inhibited in a concentration-dependent manner by SQ29548 (10(-8) M to 10(-7) M) and BM13505 (10(-8) M to 10(-6) M). However, the inhibition was associated with a decrease in maximal response. 7 Maximal responses of porcine coronary artery to U46619 (1 mu M) and 8-epi PGF(2 alpha), (30 mu M) were inhibited in a concentration-dependent manner by SQ29548 with IC50 values 99 +/- 12.36 nM and 46.5 +/- 18.67 nM, respectively. 8 Although ovine coronary arteries did not constrict to 8-epi PGF(2 alpha) pre-incubation of these vessels with 8-epi PGF(2 alpha) caused a rightward shift of the U46619 response curve in a concentration-dependent manner. 9 Pre-incubation of porcine coronary arteries with 8-epi PGF(2 alpha) competitively inhibited responses to U46619 with a Schild slope of 0.99 and a pA(2) of 6.13. 10 We conclude that 8-epi PGF(2 alpha) is a vasoconstrictor within porcine and bovine coronary arteries, with a potency approximately twice that of PGF(2 alpha) but 5-20 times lower than U46619. The data suggest that 8-epi PGF(2 alpha) is acting as a partial agonist on the TP-receptor in the coronary vasculature.
引用
收藏
页码:1276 / 1280
页数:5
相关论文
共 23 条
[1]  
Austen W G, 1975, Circulation, V51, P5
[2]   EFFECTS OF A NOVEL PROSTAGLANDIN, 8-EPI-PGF2-ALPHA, IN RABBIT LUNG INSITU [J].
BANERJEE, M ;
KANG, KH ;
MORROW, JD ;
ROBERTS, LJ ;
NEWMAN, JH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (03) :H660-H663
[3]   THE FREE-RADICAL SYSTEM IN ISCHEMIC-HEART-DISEASE [J].
CHANDRA, M ;
CHANDRA, N ;
AGRAWAL, R ;
KUMAR, A ;
GHATAK, A ;
PANDEY, VC .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1994, 43 (02) :121-125
[4]   EVIDENCE FOR THE EXISTENCE OF F2-ISOPROSTANE RECEPTORS ON RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
FUKUNAGA, M ;
MAKITA, N ;
ROBERTS, LJ ;
MORROW, JD ;
TAKAHASHI, K ;
BADR, KF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (06) :C1619-C1624
[5]   THROMBOXANE A(2) RECEPTORS [J].
HALUSHKA, PV ;
ALLAN, CJ ;
DAVISBRUNO, KL .
JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1995, 12 (2-3) :361-378
[6]   LIPID-PEROXIDATION AND ENDOTHELIAL-CELL INJURY - IMPLICATIONS IN ATHEROSCLEROSIS [J].
HENNIG, B ;
CHOW, CK .
FREE RADICAL BIOLOGY AND MEDICINE, 1988, 4 (02) :99-106
[7]   CLONING AND EXPRESSION OF CDNA FOR A HUMAN THROMBOXANE-A2 RECEPTOR [J].
HIRATA, M ;
HAYASHI, Y ;
USHIKUBI, F ;
YOKOTA, Y ;
KAGEYAMA, R ;
NAKANISHI, S ;
NARUMIYA, S .
NATURE, 1991, 349 (6310) :617-620
[8]   ANTIOXIDANT STATUS IN RELATION TO FREE-RADICAL PRODUCTION DURING STABLE AND UNSTABLE ANGINAL SYNDROMES [J].
JAYAKUMARI, N ;
AMBIKAKUMARI, V ;
BALAKRISHNAN, KG ;
IYER, KS .
ATHEROSCLEROSIS, 1992, 94 (2-3) :183-190
[9]  
KENAKIN T, 1993, PHARM ANAL DRUG RECE, P315
[10]  
Kromer BM, 1996, BRIT J PHARMACOL, V118, pP87